Wanbury Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 1,36,108 shares,. Its Average Traded Price (ATP) is ₹173.23, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 10 @ ₹170.40.
Wanbury has an upper circuit limit of ₹214.16 and a lower circuit limit of ₹142.78. The total value traded stands at ₹2.36 CR, and the delivery percentage for the day is 45.63%.
The stock is currently traded with a market lot size of 1. Wanbury also offers a dividend yield of 0%.
Wanbury Share Price Chart
Wanbury Share Key Metrics
Volume
1.36 L
Market Cap
624.05 CR
LTQ@LTP
10@170.40
ATP
173.23
Var Margin
25.17 %
Circuit Range
142.78-214.16
Delivery %
45.63 %
Value
2.36 CR
ASM/GSM
No
Market Lot
1
Wanbury Resistance and Support
Pivot 179.6
Resistance
First Resistance
185.79
Second Resistance
193.12
Third Resistance
199.31
Support
First Support
172.27
Second Support
166.08
Third Support
158.75
Wanbury Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2024-25
- 2025-26
- 2022-23
- 2023-24
- 2026-27
Total Promoters
Wanbury Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-02-05 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-05-15 | Audited Results |
| 2025-02-12 | Quarterly Results & Others |
| 2024-08-12 | Quarterly Results |
Wanbury News
Wanbury Ltd - 524212 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Wanbury received 11 'No DMF Deficiency' letters from the USFDA for its APIs including Metformin HCl. The company also announced new business in Saudi Arabia and Mexico with an annual revenue potential of Rs.10 crore and Rs.15 crore, respectively.
Oct 16 2026 13:12:35
Wanbury Ltd - 524212 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
Wanbury Limited's subsidiary has launched the berrysoft baby product range, marking its strategic entry into the paediatric dermatology segment. The company has already secured GST registrations in five states and CFA drug licenses in four cities.
Oct 12 2026 14:57:33
Wanbury Ltd - 524212 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Wanbury launched its 'berrysoft' baby product range through its subsidiary Wanbury Skin Health Limited. This marks the company's strategic entry into the Paediatric Dermatology segment, supported by GST registrations in 5 states.
Oct 12 2026 13:28:19
Wanbury Ltd - 524212 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Wanbury filed DMFs for Tramadol HCl in South Africa and Metformin HCl in Philippines and Singapore. The company also received EDQM approval for Paroxetine HCl and TGA compliance acceptance, ensuring continued API supply to the Australian market.
Oct 08 2026 13:04:49
Wanbury Management
| Name | Position |
|---|---|
| K Chandran | Whole Time Director |
| Mohan Kumar Rayana | Whole Time Director |
Wanbury Similar Stocks
Hexagon Nutrition Ltd.
60.09
-1.27 (2.07%)
Valiant Laboratories Ltd.
125.87
-2.56 (1.99%)
Kilitch Drugs (India) Ltd.
202.29
0.05 (0.02%)
Zim Laboratories Ltd.
124.00
-2.22 (1.76%)
Gaudium IVF and Women Health Ltd.
91.23
-0.88 (0.96%)
Amanta Healthcare Ltd.
165.71
2.64 (1.62%)
Influx Healthtech Ltd.
251.25
-5.75 (2.24%)
Osel Devices Ltd.
346.35
6.60 (1.94%)
Chandan Healthcare Ltd.
219.00
0.40 (0.18%)
Accent Microcell Ltd.
619.00
26.50 (4.47%)
Wanbury FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in WANBURY
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC